Fundz

Arcreal Raises $5.4M Pre-Series A to Develop Dental AI Foundation Model and Expand to U.S.

PRIVATEDec 17, 2025

Amount Raised

$5.4 Million

Round Type

Pre-Series A

GangnamBiotechnologySoftwareHealth CareArtificial Intelligence

Investors

Soo Investment CapitalSchmidtSDB InvestmentDSC Investment

Description

Arcreal, a Korean AI healthcare company, has secured $5.4 million in Pre-Series A funding from DSC Investment, SDB Investment, Schmidt, and Soo Investment Capital. This funding will aid Arcreal in developing its dental AI technology and expanding into the U.S. market. The company has a strong foundation with key medical device approvals and plans to accelerate its global sales

Quick answer

Arcreal raised $5.4 Million in a Pre-Series A round, dated December 17, 2025. Investors: Soo Investment Capital, Schmidt, SDB Investment and DSC Investment. Arcreal is based in Gangnam, Seoul, South Korea.

How much did Arcreal raise?
Arcreal raised $5.4 Million in a Pre-Series A round on December 17, 2025.
Who invested in Arcreal?
Soo Investment Capital, Schmidt, SDB Investment and DSC Investment are named as investors in this round.
What does Arcreal do?
Arcreal is a Korean AI healthcare company focused on developing innovative intraoral scanners that utilize proprietary technology to achieve high performance comparable to premium global brands.
Where is Arcreal based and how big is it?
Arcreal is based in Gangnam, Seoul, South Korea.
Who are the decision-makers at Arcreal?
Fundz holds 2 contacts at Arcreal, including the Chief Operating Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Software around the same time

Companies in the same sectors as Arcreal that raised within 45 days of this round, from Fundz verified event records.

  • PulseAI raised an undisclosed amount (Seed) on January 12, 2026.
  • MedReddie raised $1.2M on November 25, 2025.
  • Synthio Labs raised $5M (Seed) on November 19, 2025.
  • Cursor raised $2.3B (Funding Round) on November 13, 2025.
  • Shuttle Pharmaceutical Holdings raised $2.5M (Post-IPO Equity) on November 3, 2025.
  • ORamaVR raised $4.5M (Seed) on January 30, 2026.

Who to call at Arcreal, and when

A new round usually means Arcreal is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Arcreal raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Arcreal, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Arcreal. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Arcreal

Location

Gangnam, Seoul, South Korea

About

Arcreal is a Korean AI healthcare company focused on developing innovative intraoral scanners that utilize proprietary technology to achieve high performance comparable to premium global brands. The company has received multiple medical device approvals, including U.S. FDA and European CE MDR, paving the way for global commercialization. Arcreal is recognized for its comprehensive capabilities, covering software engines, AI models, and hardware design. The firm aims to lead the dental AI market by enhancing patient treatment through advanced 3D vision technology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Arcreal raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsAlice S., Chief Operating OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Arcreal's next move

See what Strategic adds

Arcreal raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.